Martin Christopher Nathan
CIK: 0002097992
Director
Primary company: Oruka Therapeutics, Inc. (ORKA)
Martin Christopher Nathan is a corporate insider at Oruka Therapeutics, Inc. (ORKA) filing SEC Form 4 transactions. 5 transactions across 2 companies. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 16,377 | $35.59 | $583K | 16,377 | 6/5/2026 Filed: 6/5/2026 | Filing → | |
| Award | 9,136 | $55.23 | $505K | 9,136 | 6/2/2026 Filed: 6/2/2026 | Filing → | |
| Award | 47,250 | $5.59 | $264K | 47,250 | 5/11/2026 Filed: 5/11/2026 | Filing → | |
| Award | 35,000 | - | - | 35,000 | 12/11/2025 Filed: 12/11/2025 | Filing → | |
| Award | 45,150 | - | - | 45,150 | 11/19/2025 Filed: 11/24/2025 | Filing → |
Type
Award
Shares
16,377
Price
$35.59
Value
$583K
Type
Award
Shares
9,136
Price
$55.23
Value
$505K
Type
Award
Shares
47,250
Price
$5.59
Value
$264K
Type
Award
Shares
35,000
Price
-
Value
-
Type
Award
Shares
45,150
Price
-
Value
-
AI Agent
Try asking...